About this trial
POQS-Boosted is a prospective observational study during which individuals who received Booster vaccination against mpox with the MVA-BN vaccine will be invited to provide biological samples at multiple times over the course of two years.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Is scheduled to receive a booster dose of MVA-BN
≥18 years
Willingness to provide written informed consent
Willingness to follow the study schedule
Disqualifiers
None
Trial population
Individuals who received MVA-BN booster vaccination will be asked to participate in "POQS-Boosted"
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Orthopoxvirus-specific serum binding and neutralising antibody titre
To describe the evolution of the orthopoxvirus-specific serum antibody response up to two years after MVA-BN booster vaccination
Secondary outcomes
Orthopoxvirus-specific systemic T- and B cell-mediated immune responses to MPXV
To describe the evolution of the orthopoxvirus-specific systemic cellular immune response up to two years after MVA-BN booster vaccination
MPXV-specific IgA in saliva and anorectal samples; T and B cell-mediated immune responses to MPXV, measured on saliva and anorectal samples
To describe the evolution of the orthopoxvirus-specific mucosal antibody \& cellular immune response up to two years after MVA-BN booster vaccination
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: